The sub-Saharan Africa position statement on the redefinition of fatty liver disease: from NAFLD to MAFLD.
暂无分享,去创建一个
Abdulmunem A Abdo | P. Ocama | D. Ndububa | Y. Awuku | Y. Fouad | Reda Elwakil | C. Spearman | H. Desalegn | O. Ojo | M. Ng’wanasayi | Medhat Elsahhar | M. Borodo | R. Ally | M. M. Borodo | A. A. Abdo
[1] Mai Mehrez,et al. The NAFLD‐MAFLD debate: Eminence vs evidence , 2020, Liver international : official journal of the International Association for the Study of the Liver.
[2] M. Silva,et al. The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease. , 2020, The lancet. Gastroenterology & hepatology.
[3] G. Shiha,et al. Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa. , 2020, The lancet. Gastroenterology & hepatology.
[4] A. Kengne,et al. How well are non-communicable disease services being integrated into primary health care in Africa: A review of progress against World Health Organization’s African regional targets , 2020, PloS one.
[5] J. Dufour,et al. Redefining fatty liver disease: an international patient perspective. , 2020, The lancet. Gastroenterology & hepatology.
[6] V. Wong,et al. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease , 2020, Hepatology International.
[7] S. Bollipo,et al. What's in a name? Renaming ‘NAFLD’ to ‘MAFLD’ , 2020, Liver international : official journal of the International Association for the Study of the Liver.
[8] V. Wong,et al. A new definition for metabolic associated fatty liver disease: an international expert consensus statement. , 2020, Journal of hepatology.
[9] A. Sié,et al. Epidemiology of multimorbidity in conditions of extreme poverty: a population-based study of older adults in rural Burkina Faso , 2020, BMJ Global Health.
[10] A. Sanyal,et al. MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease. , 2020, Gastroenterology.
[11] Dan J Stein,et al. Burden of non-communicable diseases in sub-Saharan Africa, 1990-2017: results from the Global Burden of Disease Study 2017. , 2019, The Lancet. Global health.
[12] S. Vento,et al. Liver cirrhosis in sub-Saharan Africa: neglected, yet important. , 2018, The Lancet. Global health.
[13] N. Sattar,et al. Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease , 2018, BMC Medicine.
[14] C. Mathers,et al. Acting on non-communicable diseases in low- and middle-income tropical countries , 2018, Nature.
[15] L. Henry,et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention , 2018, Nature Reviews Gastroenterology & Hepatology.
[16] K. Narayan,et al. Global noncommunicable diseases--lessons from the HIV-AIDS experience. , 2011, The New England journal of medicine.
[17] B. Lambdin,et al. Integration of HIV/AIDS services into African primary health care: lessons learned for health system strengthening in Mozambique - a case study , 2010, Journal of the International AIDS Society.
[18] Y. Kinfu,et al. The health worker shortage in Africa: are enough physicians and nurses being trained? , 2009, Bulletin of the World Health Organization.